Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis
Clinical trial NCT00141830 · COMPLETED
Trial details
- NCT number
- NCT00141830
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2006-10-19
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.